Clinical Trials Directory

Trials / Unknown

UnknownNCT02297633

Evaluation of Reactive Oxygen Metabolites in the Value of COPD

System Evaluation of Reactive Oxygen Metabolites in the Value of Chronic Obstructive Pulmonary Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
320 (estimated)
Sponsor
Beijing Chao Yang Hospital · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study through the long-term observation followed up for 2 years to find the change of the COPD patients blood ROMs, systematically evaluate the relationship between ROMs and the severity of COPD. Evaluate the differences of prognosis between the different oxidative stress level (according to the level of ROMs are divided into higher and normal phenotype). Explore the new oxidative stress evaluation index ROMs application value in COPD.

Detailed description

Reactive oxygen metabolites (reactive oxygen metabolites, ROMs) test is a method by measuring the total reactive oxygen metabolites (ROMs) content in blood so as to evaluate the overall level of oxidative stress in the human body .Our previous studies have established the method of detecting ROMs which is suitable for fully automatic biochemical analyser.Our study through the long-term observation followed up for 2 years to find the change of the COPD patients blood ROMs, systematically evaluate the relationship between ROMs and the severity of COPD. Evaluate the differences of prognosis between the different oxidative stress level (according to the level of ROMs are divided into higher and normal phenotype). Explore the new oxidative stress evaluation index ROMs application value in COPD.

Conditions

Timeline

Start date
2014-10-01
Primary completion
2017-05-01
Completion
2017-07-01
First posted
2014-11-21
Last updated
2014-11-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02297633. Inclusion in this directory is not an endorsement.